Blending of components play vital role in the manufacturing of pharmaceutical products where accuracy and consistency in the formulation are the key specifications. Blending ensures homogeneous mixture of Active Pharmaceutical Ingredient and excipients that are required in the manufacturing of drugs. Apart from mixing, objectives such as preparing fine emulsions, reducing particle size, carrying out chemical reactions, manipulating rheology, dissolving components, and facilitating heat transfer can be achieved using blenders.

Various types of products demand for different types of blending equipment. Different types of blenders based on geometries are available from blender manufacturers based on different mechanism such as double cone blenders, v-blenders, octagonal blenders, ribbon blenders, paddle blenders, vertical screw blenders, plow mixer, and double paddle mixer. Depending on dry mixing or high shear mixing and emulsification or high shear mixing and powder dispersion into liquid users can chose among various products. Blenders are also available in different capacities based on the need.

Pharmaceutical Blenders Market Dynamics

Technologically advanced pharmaceutical blenders are expected to enhance the performance of pharmaceutical blenders. To enhance the performance and ensure homogeneous mixture of drug blenders are incorporated with analytical tools which monitors which checks the uniformity necessary for drug manufacturing.

For easy work flow, manufacturers introduced bin blenders in which container is detached for the drive and can be transported to next process of operation without discharging its contents into a secondary vessel, which reduces the chance of contamination of the pharma product. Such technological advancement to ease the workflow is expected to supply better options, and adding new product range to the market.

Moreover, with the rapid growth of pharmaceutical manufacturing and generic medicine manufacturing industries, more companies are investing into this market, which is expected to increase the demand for pharmaceutical blenders and fuel growth of the market over the forecast period. Increasing patent expiration is in turn increasing the growth of generic drug manufacturers which is expected to fuel growth of the pharmaceutical blenders market over the forecast period.

The pharmaceutical manufacturing market is growing rapidly, owing to increasing prevalence of chronic diseases and increasing demand for drugs. To fulfill the market demands, many companies and investors are investing and developing more manufacturing units, which is expected to fuel the pharmaceutical blenders market growth.

Increasing research and development initiatives for the development of novel drugs for diseases such as cancer, diabetes or cardiovascular disorders is expected to drive growth of the pharmaceutical blenders market. For instance, as in 2015, according to facts and figures published by the International Federation of Pharmaceutical Manufacturers & Associations, over 6000 drug entities were in preclinical trial.

Pharmaceutical Blenders Market - Regional Analysis

On the basis of the region, the global pharmaceutical blenders market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America pharmaceutical blender market owes dominant position in the global market over the forecast period, owing to rapid growth in pharmaceutical industries in the region.

According to the International Trade Administration 2016, the U.S. is a major hub for drug manufacturing, as imports account only for around a quarter of the market by value. The manufacturing market in the U.S. is witnessing significant growth, which is expected to fuel growth of the pharmaceutical blenders market over the forecast period.

However, Asia Pacific pharmaceutical blenders market is expected to witness high CAGR over the forecast period, owing to emerging generic drug manufacturers in economies such as India and China. Moreover, favorable government schemes propel growth of pharmaceutical companies in the region, thereby driving growth of the market.

For instance, under the ‘Pharma Vision 2020’, the Government of India reduced the approval time for new facilities to propel investments for drug manufacturers in this region. Such initiatives are expected to attract foreign investors for the development of new manufacturing units, in turn increasing the demand for pharmaceutical blenders and further driving growth of the market.

Pharmaceutical Blenders Market – Competitive Landscape

Some of the key players operating in the global pharmaceutical blenders market include GEA Process Engineering Ltd, SERVOLIFT GmbH, Charles Ross and Son Company, KADY International, Frain Industries, Charles Ross & Son Company, ARDE Barinco, Inc., Admix, Inc., Reynolds Industries, Inc., and WAM Inc.

Pharmaceutical Blenders Market - Taxonomy

On the basis of product type, the global pharmaceutical blenders market is segmented into: